Search results

3126 results for All evidence

Sorted by Date . Sort by Relevance

Source: European Medicines Agency - EMA Remove Source: European Medicines Agency - EMA filter
Source: NHS Improvement Remove Source: NHS Improvement filter
Source: UK Blood Transfusion and Tissue Transplantation Services - UKBTS Remove Source: UK Blood Transfusion and Tissue Transplantation Services - UKBTS filter
Source: British Dietetic Association - BDA Remove Source: British Dietetic Association - BDA filter
Source: Road Safety Observatory Remove Source: Road Safety Observatory filter
Source: Action on Hearing Loss Remove Source: Action on Hearing Loss filter
Source: Children's Brain Tumour Research Centre Remove Source: Children's Brain Tumour Research Centre filter

Showing results 1 to 50. View options for downloading these results.

Add this result to my export selection

Human medicines: highlights of 2020

Source:

European Medicines Agency - EMA (Remove filter)

Published by European Medicines Agency, 21 January 2021

The EMA has published an overview of its key recommendations in 2020 on the authorisation and safety monitoring of medicines for human use. 97 medicines were recommended for marketing authorisation.

Read Summary

Type:

Medicines Current Awareness (Add filter)
Add this result to my export selection

European Medicines Agency (EMA) highlights key role of healthcare professionals (HCPs) in fostering confidence in COVID-19 vaccines

Source:

European Medicines Agency - EMA (Remove filter)

Published by European Medicines Agency, 19 January 2021

EMA endorsed this joint statement by the International Coalition of Medicines Regulatory Authorities, in order to support HCPs when speaking to and reassuring the public that the regulatory processes...

Read Summary

Type:

Medicines Current Awareness (Add filter)
Add this result to my export selection

Human medicine European public assessment report (EPAR): Dificlir (updated)

Source:

European Medicines Agency - EMA (Remove filter)

18 January 2021

Dificlir { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News"

Type:

Prescribing and Technical Information (Add filter)
Add this result to my export selection

Human medicine European public assessment report (EPAR): Clopidogrel TAD (updated)

Source:

European Medicines Agency - EMA (Remove filter)

18 January 2021

Clopidogrel TAD { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via":

Type:

Prescribing and Technical Information (Add filter)
Add this result to my export selection

Human medicine European public assessment report (EPAR): Bortezomib Fresenius Kabi (updated)

Source:

European Medicines Agency - EMA (Remove filter)

18 January 2021

Bortezomib Fresenius Kabi { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn"

Type:

Prescribing and Technical Information (Add filter)
Add this result to my export selection

Human medicine European public assessment report (EPAR): Toujeo (previously Optisulin) (updated)

Source:

European Medicines Agency - EMA (Remove filter)

15 January 2021

Toujeo (previously Optisulin) { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn"

Type:

Prescribing and Technical Information (Add filter)
Add this result to my export selection

Human medicine European public assessment report (EPAR): Tresiba (updated)

Source:

European Medicines Agency - EMA (Remove filter)

15 January 2021

Tresiba { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News"

Type:

Prescribing and Technical Information (Add filter)
Add this result to my export selection

Human medicine European public assessment report (EPAR): Brintellix (updated)

Source:

European Medicines Agency - EMA (Remove filter)

15 January 2021

Brintellix { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via":

Type:

Prescribing and Technical Information (Add filter)
Add this result to my export selection

Human medicine European public assessment report (EPAR): Busulfan Fresenius Kabi (updated)

Source:

European Medicines Agency - EMA (Remove filter)

15 January 2021

Busulfan Fresenius Kabi { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }

Type:

Prescribing and Technical Information (Add filter)
Add this result to my export selection

Human medicine European public assessment report (EPAR): INOmax (updated)

Source:

European Medicines Agency - EMA (Remove filter)

15 January 2021

INOmax { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News"

Type:

Prescribing and Technical Information (Add filter)
Add this result to my export selection

Human medicine European public assessment report (EPAR): Grepid (updated)

Source:

European Medicines Agency - EMA (Remove filter)

15 January 2021

Grepid { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News"

Type:

Prescribing and Technical Information (Add filter)
Add this result to my export selection

Human medicine European public assessment report (EPAR): Lenvima (updated)

Source:

European Medicines Agency - EMA (Remove filter)

15 January 2021

Lenvima { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News"

Type:

Prescribing and Technical Information (Add filter)
Add this result to my export selection

Human medicine European public assessment report (EPAR): Tyverb (updated)

Source:

European Medicines Agency - EMA (Remove filter)

15 January 2021

Tyverb { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News"

Type:

Prescribing and Technical Information (Add filter)
Add this result to my export selection

Human medicine European public assessment report (EPAR): Kisplyx (updated)

Source:

European Medicines Agency - EMA (Remove filter)

14 January 2021

Kisplyx { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News"

Type:

Prescribing and Technical Information (Add filter)
Add this result to my export selection

Human medicine European public assessment report (EPAR): Zonisamide Mylan (updated)

Source:

European Medicines Agency - EMA (Remove filter)

14 January 2021

Zonisamide Mylan { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via":

Type:

Prescribing and Technical Information (Add filter)
Add this result to my export selection

Human medicine European public assessment report (EPAR): Zonegran (updated)

Source:

European Medicines Agency - EMA (Remove filter)

14 January 2021

Zonegran { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News"

Type:

Prescribing and Technical Information (Add filter)
Add this result to my export selection

Human medicine European public assessment report (EPAR): Exelon (updated)

Source:

European Medicines Agency - EMA (Remove filter)

14 January 2021

Exelon { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News"

Type:

Prescribing and Technical Information (Add filter)
Add this result to my export selection

Human medicine European public assessment report (EPAR): Lixiana (updated)

Source:

European Medicines Agency - EMA (Remove filter)

14 January 2021

Lixiana { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News"

Type:

Prescribing and Technical Information (Add filter)
Add this result to my export selection

Human medicine European public assessment report (EPAR): Prometax (updated)

Source:

European Medicines Agency - EMA (Remove filter)

14 January 2021

Prometax { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News"

Type:

Prescribing and Technical Information (Add filter)
Add this result to my export selection

Human medicine European public assessment report (EPAR): Rubraca (updated)

Source:

European Medicines Agency - EMA (Remove filter)

14 January 2021

Rubraca { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News"

Type:

Prescribing and Technical Information (Add filter)
Add this result to my export selection

Human medicine European public assessment report (EPAR): Mayzent (updated)

Source:

European Medicines Agency - EMA (Remove filter)

14 January 2021

Mayzent { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News"

Type:

Prescribing and Technical Information (Add filter)
Add this result to my export selection

Human medicine European public assessment report (EPAR): Holoclar (updated)

Source:

European Medicines Agency - EMA (Remove filter)

14 January 2021

Holoclar { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News"

Type:

Prescribing and Technical Information (Add filter)
Add this result to my export selection

Human medicine European public assessment report (EPAR): Sebivo (updated)

Source:

European Medicines Agency - EMA (Remove filter)

14 January 2021

Sebivo { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News"

Type:

Prescribing and Technical Information (Add filter)
Add this result to my export selection

Human medicine European public assessment report (EPAR): Neulasta (updated)

Source:

European Medicines Agency - EMA (Remove filter)

14 January 2021

Neulasta { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News"

Type:

Prescribing and Technical Information (Add filter)
Add this result to my export selection

Human medicine European public assessment report (EPAR): Nexium Control (updated)

Source:

European Medicines Agency - EMA (Remove filter)

14 January 2021

Nexium Control { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via":

Type:

Prescribing and Technical Information (Add filter)
Add this result to my export selection

Human medicine European public assessment report (EPAR): Valdoxan (updated)

Source:

European Medicines Agency - EMA (Remove filter)

14 January 2021

Valdoxan { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News"

Type:

Prescribing and Technical Information (Add filter)
Add this result to my export selection

Human medicine European public assessment report (EPAR): Thymanax (updated)

Source:

European Medicines Agency - EMA (Remove filter)

14 January 2021

Thymanax { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News"

Type:

Prescribing and Technical Information (Add filter)
Add this result to my export selection

Human medicine European public assessment report (EPAR): Clopidogrel Krka (updated)

Source:

European Medicines Agency - EMA (Remove filter)

13 January 2021

Clopidogrel Krka { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via":

Type:

Prescribing and Technical Information (Add filter)
Add this result to my export selection

Human medicine European public assessment report (EPAR): Hexyon (updated)

Source:

European Medicines Agency - EMA (Remove filter)

13 January 2021

Hexyon { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News"

Type:

Prescribing and Technical Information (Add filter)
Add this result to my export selection

Human medicine European public assessment report (EPAR): Foclivia (updated)

Source:

European Medicines Agency - EMA (Remove filter)

13 January 2021

Foclivia { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News"

Type:

Prescribing and Technical Information (Add filter)
Add this result to my export selection

Human medicine European public assessment report (EPAR): Fycompa (updated)

Source:

European Medicines Agency - EMA (Remove filter)

13 January 2021

Fycompa { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News"

Type:

Prescribing and Technical Information (Add filter)
Add this result to my export selection

Human medicine European public assessment report (EPAR): Stelara (updated)

Source:

European Medicines Agency - EMA (Remove filter)

13 January 2021

Stelara { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News"

Type:

Prescribing and Technical Information (Add filter)
Add this result to my export selection

Human medicine European public assessment report (EPAR): Phesgo

Source:

European Medicines Agency - EMA (Remove filter)

13 January 2021

Phesgo { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News"

Type:

Prescribing and Technical Information (Add filter)
Add this result to my export selection

EMA receives application for conditional marketing authorisation of COVID-19 Vaccine AstraZeneca

Source:

European Medicines Agency - EMA (Remove filter)

Published by European Medicines Agency, 12 January 2021

The assessment will proceed under an accelerated timeline, and an opinion on the marketing authorisation for use in the EU could be issued by 29 January.

Read Summary

Type:

Medicines Current Awareness (Add filter)
Add this result to my export selection

Cyberattack on European Medicines Agency - update

Source:

European Medicines Agency - EMA (Remove filter)

Published by European Medicines Agency, 12 January 2021

Ongoing investigation found some of unlawfully accessed documents related to COVID-19 medicines & vaccines belonging to third parties have been leaked on internet. Regulatory network remain fully...

Read Summary

Type:

Medicines Current Awareness (Add filter)
Add this result to my export selection

Human medicine European public assessment report (EPAR): Amyvid (updated)

Source:

European Medicines Agency - EMA (Remove filter)

12 January 2021

Amyvid { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News"

Type:

Prescribing and Technical Information (Add filter)
Add this result to my export selection

Human medicine European public assessment report (EPAR): Enbrel (updated)

Source:

European Medicines Agency - EMA (Remove filter)

12 January 2021

Enbrel { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News"

Type:

Prescribing and Technical Information (Add filter)
Add this result to my export selection

Human medicine European public assessment report (EPAR): Comirnaty (updated)

Source:

European Medicines Agency - EMA (Remove filter)

12 January 2021

Comirnaty { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News"

Type:

Prescribing and Technical Information (Add filter)
Add this result to my export selection

Human medicine European public assessment report (EPAR): Orfadin (updated)

Source:

European Medicines Agency - EMA (Remove filter)

11 January 2021

Orfadin { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News"

Type:

Prescribing and Technical Information (Add filter)
Add this result to my export selection

Human medicine European public assessment report (EPAR): Ozempic (updated)

Source:

European Medicines Agency - EMA (Remove filter)

11 January 2021

Ozempic { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News"

Type:

Prescribing and Technical Information (Add filter)
Add this result to my export selection

Human medicine European public assessment report (EPAR): Ocrevus (updated)

Source:

European Medicines Agency - EMA (Remove filter)

11 January 2021

Ocrevus { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News"

Type:

Prescribing and Technical Information (Add filter)
Add this result to my export selection

Human medicine European public assessment report (EPAR): Axumin (updated)

Source:

European Medicines Agency - EMA (Remove filter)

11 January 2021

Axumin { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News"

Type:

Prescribing and Technical Information (Add filter)
Add this result to my export selection

Human medicine European public assessment report (EPAR): Panretin (updated)

Source:

European Medicines Agency - EMA (Remove filter)

11 January 2021

Panretin { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News"

Type:

Prescribing and Technical Information (Add filter)
Add this result to my export selection

Human medicine European public assessment report (EPAR): BeneFIX (updated)

Source:

European Medicines Agency - EMA (Remove filter)

11 January 2021

BeneFIX { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News"

Type:

Prescribing and Technical Information (Add filter)
Add this result to my export selection

Human medicine European public assessment report (EPAR): Daurismo (updated)

Source:

European Medicines Agency - EMA (Remove filter)

08 January 2021

Daurismo { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News"

Type:

Prescribing and Technical Information (Add filter)
Add this result to my export selection

Human medicine European public assessment report (EPAR): Daptomycin Hospira (updated)

Source:

European Medicines Agency - EMA (Remove filter)

08 January 2021

Daptomycin Hospira { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" },

Type:

Prescribing and Technical Information (Add filter)
Add this result to my export selection

Human medicine European public assessment report (EPAR): Ninlaro (updated)

Source:

European Medicines Agency - EMA (Remove filter)

08 January 2021

Ninlaro { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News"

Type:

Prescribing and Technical Information (Add filter)
Add this result to my export selection

Human medicine European public assessment report (EPAR): Fintepla

Source:

European Medicines Agency - EMA (Remove filter)

08 January 2021

Fintepla { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News"

Type:

Prescribing and Technical Information (Add filter)
Add this result to my export selection

Human medicine European public assessment report (EPAR): Prevenar 13 (updated)

Source:

European Medicines Agency - EMA (Remove filter)

08 January 2021

Prevenar 13 { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via":

Type:

Prescribing and Technical Information (Add filter)
Add this result to my export selection

Human medicine European public assessment report (EPAR): Xyrem (updated)

Source:

European Medicines Agency - EMA (Remove filter)

08 January 2021

Xyrem { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News"

Type:

Prescribing and Technical Information (Add filter)

Page 1 of 63

Search results

Filter

Filter by Date

Accredited

3126 results for All evidence